
Nitinol and ePTFE on a mandrel during a materials processing demonstration at the Aptyx R&D and manufacturing facility in Charlotte, North Carolina [Photo by Jim Hammerand/Medical Design & Outsourcing]
Expanded polytetrafluoroethylene (ePTFE) has become a staple in the medical device industry for applications ranging from vascular grafts to stent encapsulations and more. It’s known for chemical inertness, biocompatibility, flexibility, and durability.
What may surprise engineers is that ePTFE is not a single, uniform material. It takes several forms with varying properties, each defined by the processing from base resin to final material.
The processing of ePTFE begins with fine PTFE resin that is combined with a lubricant and turned into a billet. This billet (or preform) is then extruded as a rod, tube, or sheet. After removing the lubricant, the material is stretched under controlled conditions, creating the characteristic microstructure.
Selecting the right form of ePTFE in alignment with clinical needs early in the design process is essential for success. A graft designed for vascular access will behave differently from membrane or tape intended for stent encapsulation
Microstructure is ePTFE’s advantage
The versatility of ePTFE is a result of its unique microstructure. Unlike solid PTFE, ePTFE is expanded through a controlled stretching process that creates a porous network of nodes interconnected by fibrils, which gives ePTFE its distinctive combination of strength, flexibility, and permeability.
From a design perspective, key parameters in this microstructure include porosity, fibril orientation, and node density. These characteristics directly influence how the material behaves in a clinical setting. For example, increasing the porosity can improve permeability, but may reduce mechanical strength. Conversely, a denser structure enhances strength and durability, but may limit tissue integration.

An ePTFE vascular graft imaged with scanning electron microscopy [Image courtesy of Aptyx]
On the other hand, membranes can be made biaxially, which allows for similar strength in both directions and shows as a mesh or lattice-like structure. Tapes and ribbons often exhibit highly oriented fibril networks, contributing to their ability to stretch preferentially in one direction.
Understanding these structural differences is essential. Engineers are often surprised to learn that two materials with the same base polymer can behave in an entirely different way based on how the microstructure is engineered.
Tubes versus membranes versus tapes

An ePTFE membrane imaged with scanning electron microscopy [Image courtesy of Aptyx]
The microstructure of tubes, typically used for vascular grafts or stent encapsulations, is usually highly oriented longitudinally which provides axial strength. Because fibrils can bend and straighten, these tubes have excellent flexibility.
Membranes are typically thin, porous sheets. They are commonly used in applications such as filtration and stent encapsulation. Engineers may initially assume that all ePTFE membranes behave similarly, but subtle differences in porosity and thickness can dramatically alter performance. Membranes are especially preferred in applications where the delivery system’s profile is a driving factor behind the design requirements, as membranes can be produced at a thickness of less than 10 microns. (For reference, human hair typically ranges from 50 to 100 microns.)

An ePTFE tape imaged with scanning electron microscopy [Image courtesy of Aptyx]
Final thoughts
With ePTFE, there is no one-size-fits-all solution. Performance is customizable, but the first step to success is tailoring microstructure to the design requirements and clinical needs. The material’s node-fibril microstructure enables a wide range of characteristics, requiring careful consideration of form, structure, and application.
While ePTFE is versatile, the degree to which properties can be adjusted has made this material a hot topic in the medical device industry. When approached thoughtfully, ePTFE offers serious potential for many medical device applications. When used improperly, it can lead to costly redesigns and project delays.

Aptyx R&D Engineer Matt Navarro with ePTFE-covered nitinol he processed during a demonstration at the CDMO’s R&D and manufacturing facility in Charlotte, North Carolina [Photo by Jim Hammerand/Medical Design & Outsourcing]
Matt Navarro is an R&D engineer at Aptyx with seven years of experience developing ePTFE-based solutions for advanced implantable systems. His work spans endovascular, peripheral vascular, structural heart, neurovascular, and gastrointestinal applications, where he has led dozens of programs from concept through development. Navarro holds bachelor’s and master’s degrees in biomedical engineering from Clemson University.
Read more MDO Contributions and learn how to submit your own
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.



